Fibroblast Expression of Thy-1 Protects Grafts from Chronic Lung Allograft Dysfunction

Abstract

donors to 9.0yrs (8.5-9.6) with ≥40yo donors]. Conclusion:There is a disproportionate (3x) benefit in median survival by using a younger donor heart (12-24yo) in younger recipients (18-49yo) compared to ≥65yo recipients. The potential gain in number of total posttransplant years by an age-specific organ allocation should be considered in this supply-constrained climate of transplant "economics".